Changes in NO bioavailabilty regulate cardiac O2 consumption: Control by intramitochondrial SOD2 and intracellular myoglobin

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 286, Issue 1 55-1, 2004, Pages

  Li, Wei ^a   Jue, Thomas ^b   Edwards, John ^a   Wang, Xipping ^a   Hintze, Thomas H ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bradykinin; Carbachol; Myoglobin knockout mouse; S nitroso N acetyl penicillamine; Superoxide dismutase 2 heterozygous mouse; Tiron

Indexed keywords

BRADYKININ; CARBACHOL; MANGANESE SUPEROXIDE DISMUTASE; MYOGLOBIN; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SCAVENGER; SUPEROXIDE DISMUTASE; TIRON; UNCLASSIFIED DRUG; ENZYME INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOSOL; ELECTRODE; FEMALE; HEART MITOCHONDRION; HEART MUSCLE OXYGEN CONSUMPTION; HETEROZYGOTE; IN VITRO STUDY; KIDNEY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SKELETAL MUSCLE; WILD TYPE; ANIMAL; ARTICLE; BIOAVAILABILITY; DRUG EFFECT; ENZYMOLOGY; HEART MUSCLE; INTRACELLULAR MEMBRANE; KIDNEY CORTEX; LIVER; METABOLISM; MOUSE MUTANT; OXYGEN CONSUMPTION; PHENOTYPE; PHYSIOLOGY;

ANIMALS; BIOLOGICAL AVAILABILITY; BRADYKININ; CARBACHOL; ENZYME INHIBITORS; FEMALE; HETEROZYGOTE; INTRACELLULAR MEMBRANES; KIDNEY CORTEX; LIVER; MALE; MICE; MICE, KNOCKOUT; MITOCHONDRIA, HEART; MUSCLE, SKELETAL; MYOCARDIUM; MYOGLOBIN; NITRIC OXIDE; OXYGEN CONSUMPTION; PHENOTYPE; S-NITROSO-N-ACETYLPENICILLAMINE; SUPEROXIDE DISMUTASE; TIRON;

EID: 0347747971     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00730.2003     Document Type: Conference Paper

References (48)

1. Bolanos JP, Peuchen S, Heales SJ, Land JM, and Clark JB. Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J Neurochem 63: 910-916, 1994.
2. Boveris A. Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria. Methods Enzymol 105: 429-435, 1984.
3. Brown GC, Bolanos JP, Heales SJ, and Clark JB. Nitric oxide produced by activated astrocytes rapidly and reversibly inhibits cellular respiration. Neurosci Lett 193: 201-204, 1995.
4. Brown GC and Cooper CE. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett 356: 295-298, 1994.
5. Brunori M. Nitric oxide moves myoglobin centre stage. Trends Biochem Sci 26: 209-210, 2001.
6. Chance B, Sies H, and Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 59: 527-605, 1979.
7. Cleeter MW, Cooper JM, Darley-Usmar VM, Moncada S, and Schapira AH. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 345: 50-54, 1994.
8. 2 consumption in B2 receptor knockout mice in vitro. FASEB J 12: A978, 1998.
9. Drapier JC and Hibbs JB Jr. Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible. J Clin Invest 78: 790-797, 1986.
10. Flogel U, Merx MW, Godecke A, Decking UK, and Schrader J. Myoglobin: a scavenger of bioactive NO. Proc Natl Acad Sci USA 98: 735-740, 2001.
11. Freeman BA and Crapo JD. Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J Biol Chem 256: 10986-10992, 1981.
12. Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem 64: 97-112, 1995.
13. Fridovich I and Freeman B. Antioxidant defenses in the lung. Annu Rev Physiol 48: 693-702, 1986.
14. Garry DJ, Ordway GA, Lorenz JN, Radford NB, Chin ER, Grange RW, Bassel-Duby R, and Williams RS. Mice without myoglobin. Nature 395: 905-908, 1998.
15. Giulivi C, Boveris A, and Cadenas E. Hydroxyl radical generation during mitochondrial electron transfer and the formation of 8-hydroxydes-oxyguanosine in mitochondrial DNA. Arch Biochem Biophys 316: 909-916, 1995.
16. Grange RW, Meeson A, Chin E, Lau KS, Stull JT, Shelton JM, Williams RS, and Garry DJ. Functional and molecular adaptations in skeletal muscle of myoglobin-mutant mice. Am J Physiol Cell Physiol 281: C1487-C1494, 2001.
17. Granger DL and Lehninger AL. Sites of inhibition of mitochondrial electron transport in macrophage-injured neoplastic cells. J Cell Biol 95: 527-535, 1982.
18. -·) radicals. Biochim Biophys Acta 778: 579-585, 1984.
19. Haddad IY, Pataki G, Hu P, Galliani C, Beckman JS, and Matalon S. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest 94: 2407-2413, 1994.
20. 2 formation by rat heart mitochondria on substrate availability and donor age. J Bioenerg Biomembr 29: 89-95, 1997.
21. Hibbs JB Jr, Taintor RR, and Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 235: 473-476, 1987.
22. Huang TT, Carlson EJ, Raineri I, Gillespie AM, Kozy H, and Epstein CJ. The use of transgenic and mutant mice to study oxygen free radical metabolism. Ann NY Acad Sci 893: 95-112, 1999.
23. Ichihara A, Hayashi M, Hirota N, and Saruta T. Superoxide inhibits neuronal nitric oxide synthase influences on afferent arterioles in spontaneously hypertensive rats. Hypertension 37: 630-634, 2001.
24. Jackson RM, Helton ES, Viera L, and Ohman T. Survival, lung injury, and lung protein nitration in heterozygous MnSOD knockout mice in hyperoxia. Exp Lung Res 25: 631-646, 1999.
25. Kokoszka JE, Coskun P, Esposito LA, and Wallace DC. Increased mitochondrial oxidative stress in the Sod2 (+/-) mouse results in the age-related decline of mitochondrial function culminating in increased apoptosis. Proc Natl Acad Sci USA 98: 2278-2283, 2001.
26. Lebovitz RM, Zhang H, Vogel H, Cartwright J Jr,. Dionne L, Lu N, Huang S, and Matzuk MM. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci USA 93: 9782-9787, 1996.
27. Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura MP, Berger C, Chan PH, Wallace DC, and Epstein CJ. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 11: 376-381, 1995.
28. 2 kinin receptor knockout mice. Hypertension 34: 563-567, 1999.
29. Loke KE, McConnell Tuczman JM, Shesely EG, Smith CJ, Stackpole CJ, Thompson CI, Kaley G, Wolin MS, and Hintze TH. Endogeneous endothelial nitric oxide synthase derived nitric oxide is a physiological regulator of myocardial oxygen consumption. Circ Res 84: 840-845, 1999.
30. Matzuk MM, Dionne L, Guo Q, Kumar TR, and Lebovitz RM. Ovarian function in superoxide dismutase 1 and 2 knockout mice. Endocrinology 139: 4008-4011, 1998.
31. Melov S, Coskun P, Patel M, Tuinstra R, Cottrell B, Jun AS, Zastawny TH, Dizdaroglu M, Goodman SI, Huang TT, Miziorko H, Epstein CJ, and Wallace DC. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci USA 96: 846-851, 1999.
32. Pandolfo M. Molecular genetics and pathogenesis of Friedreich ataxia. Neuromuscul Disord 8: 409-415, 1998.
33. Pierce LL, Kanai AJ, Birder LA, Pitt BR, and Peterson J. The catabolic fate of nitric oxide, the nitric oxide oxidase and peroxynitrite reductase activities of cytochrome oxidase. J Biol Chem 277: 13556-13562, 2002.
34. Sahn DJ, DeMaria A, Kisslo J, and Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58: 1072-1083, 1978.
35. Schapira AH. Mitochondrial dysfunction in neurodegenerative disorders. Biochim Biophys Acta 1366: 225-233, 1998.
36. Shen W, Hintze TH, and Wolin MS. Nitric oxide. An important signaling mechanism between vascular endothelium and parenchymal cells in the regulation of oxygen consumption. Circulation 92: 3505-3512, 1995.
37. St Clair DK, Oberley TD, Muse KE, and St. Clair WH. Expression of manganese superoxide dismutase promotes cellular differentiation. Free Radic Biol Med 16: 275-282, 1994.
38. Tsan MF. Superoxide dismutase and pulmonary oxygen toxicity. Proc Soc Exp Biol Med 214: 107-113, 1997.
39. Tsan MF, White JE, Caska B, Epstein CJ, and Lee CY. Susceptibility of heterozygous MnSOD gene-knockout mice to oxygen toxicity. Am J Respir Cell Mol Biol 19: 114-120, 1998.
40. Turrens JF, Alexandre A, and Lehninger AL. Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch Biochem Biophys 237: 408-414, 1985.
41. Turrens JF and Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem J 191: 421-427, 1980.
42. Van Remmen H, Salvador C, Yang H, Huang TT, Epstein CJ, and Richardson A. Characterization of the antioxidant status of the heterozygous manganese superoxide dismutase knockout mouse. Arch Biochem Biophys 363: 91-97, 1999.
43. Van Remmen H, Williams MD, Guo Z, Estlack L, Yang H, Carlson EJ, Epstein CJ, Huang TT, and Richardson A. Knockout mice heterozygous for Sod2 show alterations in cardiac mitochondrial function and apoptosis. Am J Physiol Heart Circ Physiol 281: H1422-H1432, 2001.
44. Wegener JW, Godecke A, Schrader J, and Nawrath H. Effects of nitric oxide donors on cardiac contractility in wild-type and myoglobin-deficient mice. Br J Pharmacol 136: 415-420, 2002.
45. Wispe JR, Warner BB, Clark JC, Dey CR, Neuman J, Glasser SW, Crapo JD, Chang LY, and Whitsett JA. Human Mn-superoxide dismutase in pulmonary epithelial cells of transgenic mice confers protection from oxygen injury. J Biol Chem 267: 23937-23941, 1992.
46. Wittenberg BA and Wittenberg JB. Transport of oxygen in muscle. Annu Rev Physiol 51: 857-878, 1989.
47. Wunderlich C, Flogel U, Godecke A, Heger J, and Schrader J. Acute inhibition of myoglobin impairs contractility and energy state of iNOS-overexpressing hearts. Circ Res 92: 1352-1358, 2003.
48. Zhao G, Zhang X, Xu X, Wolin MS, and Hintze TH. Depressed modulation of oxygen consumption by endogenous nitric oxide in cardiac muscle from diabetic dogs. Am J Physiol Heart Circ Physiol 279: H520-H527, 2000.